๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

CYP17 POLYMORPHISMS AND PROSTATE CANCER OUTCOMES

โœ Scribed by Wright, Jonathan L; Lin, Daniel W; Kwon, Erika M; Kolb, Suzanne; Feng, Ziding; Koopmeiners, Joseph; Ostrander, Elaine A; Stanford, Janet L


Book ID
123478632
Publisher
Lippincott Williams and Wilkins
Year
2009
Tongue
English
Weight
51 KB
Volume
181
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


718CYP17 polymorphisms and prostate canc
โœ Mearini L.; Mearini E.; Zucchi A.; Costantini E.; Porena M. ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 158 KB
7029 CYP17 gene polymorphism in prostate
โœ Sivonova, M.; Dobrota, D.; Matakova, T.; Racay, P.; Hatok, J.; Kliment, J. ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 55 KB
CYP17 promotor polymorphism and ovarian
โœ Amanda B. Spurdle; Xiaoqing Chen; Mohammed Abbazadegan; Nicholas Martin; Soo-Kea ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 55 KB ๐Ÿ‘ 2 views

The CYP17 gene encodes the cytochrome P450c17โฃ enzyme, which functions at 2 different points in the steroid biosynthesis pathway, and is considered a candidate susceptibility gene for endocrine-related tumors. A T to C substitution polymorphism exists in the 5 promoter region of this gene, and creat

CYP17 inhibitors for prostate cancer the
โœ Tadas S. Vasaitis; Robert D. Bruno; Vincent C.O. Njar ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 375 KB